Andreas Maetzel

Senior Vice President, Medical at Kalvista Pharmaceuticals Inc. (KALV), 2021-05-28
Vp, Clinical And Regulatory at Cornerstone Therapeutics Inc (CRTX), 2014-02-04

Insider Trading: Sales See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
KALV	$25.04	40,886	$1,023,589.19	0	2021-04-29	Filing
KALV	$25.65	507	$13,004.55	0	2021-04-28	Filing
KALV	$25.54	10,000	$255,387.00	507	2021-04-28	Filing
KALV	$25.25	15,000	$378,783.00	10,507	2021-04-28	Filing
KALV	$25.50	10,620	$270,810.00	25,507	2021-04-28	Filing